• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

AstraZeneca

Heart on futuristic podium with neon lighting
Pharma

ESC: AZ digs deep on Wainua's surprise ph. 3 failure in ATTR-CM

The detailed results on CARDIO-TTRansform were among the most anticipated readouts at this year’s European Society of Cardiology Congress in Munich.
Fraiser Kansteiner Aug 29, 2026 1:35pm
Tezspire

Amgen, AZ's Tezspire lands ph. 3 eosinophilic esophagitis win

Aug 27, 2026 10:17am
law and order concept

Courts reject Medicare price negotiation lawsuits from Merck, AZ

Aug 24, 2026 3:47pm
Boehringer Ingelheim booth at AACR 2026

Boehringer again rises up rare disease reputation rankings

Aug 20, 2026 4:29am
AZ

AstraZeneca dual lung cancer wins softened by bispecific fail

Aug 17, 2026 10:56am
AZ

ICER says AZ's Baxfendy doesn't clear its cost-effectiveness bar

Aug 13, 2026 11:37am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings